NEWS ARCHIVE
2020-08-12 03:15:40 | MS researcher gets it in gear
Andrew Mendiola, PhD featured in Momentum, the official magazine of the National MS Society
2020-07-21 02:58:32 | Revealing the genetic signature of neurodegenerative disease
To read full article, click here.
2020-07-21 00:00:00 | Revealing the genetic signature of neurodegenerative disease Learn more
2020-04-16 02:54:15 | Scientists Build Map of Toxic Immune Cells Contributing to Neurodegeneration in MS
To read full article, click here.
2020-04-14 02:51:25 | ‘Tox-seq’ atlas of immune cells identified for neurodegenerative therapies
Click here to read full article.
2020-04-14 00:00:00 | Tox-seq’ atlas of immune cells identified for neurodegenerative therapies Learn more
2020-04-13 02:45:26 | Toxic Cell Atlas Guides New Therapies for Neurodegeneration
October 31, 2019 Click here to read the full article.
2020-02-09 20:00:20 | Mark Petersen – UCSF New Frontier Research ( NFR) Award Recipient
Dr. Petersen has not only been promoted to Associate Professor at the Department of Pediatrics at UCSF; he is also the recipient of the UCSF New Frontier Research pilot award to expand his studies on ACVR1 in neurological diseases.
The New Frontier Research (NFR) is part of the UCSF Sandler Program for Breakthrough Biomedical Research designed to further biomedical discoveries, encourage new areas of exploration , and support emerging talent.
2019-12-26 00:00:00 | Ten Greeks Who Left Their Mark in 2019 Learn more
2019-11-15 19:12:14 | Andrew Mendiola shared his research and his Bike MS experience at the National Multiple Sclerosis Leadership Conference
November 15, 2019
2019-11-10 19:43:14 | Mark Petersen is awarded an NIH/NINDS fellowship entitled, “Fibrinogen-Mediated Mechanisms of Preterm Infant Brain Injury.”
November 10, 2019
2019-10-31 22:54:51 | $4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s Disease
October 31, 2019 Click here to read the full article. Jorge Palop (left) and Katerina Akassoglou (right) received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
2019-10-08 23:01:31 | New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease
October 8, 2019 Click here to read full article. Gladstone team of (from left) Jae Kyu Ryu, Anke Meyer-Franke, Katerina Akassoglou, and Stephen Freedman worked with entrepreneur Edward Spack to launch MedaRed, Inc.
2019-10-03 00:00:00 | Deficits in the Blood-Brain Barrier Play a Role in Alzheimer’s Disease Pathology A New 3D Tissue Model Provides a Potential Target for Developing Therapy Learn more
2019-07-11 21:34:44 | Momentum, NMSS Magazine – A big part of the MS puzzle
July 11, 2019 Click here to view article. Momentum_Interview 2019
2019-07-08 00:00:00 | MedaRed Raises $6.5 Million and Appoints Industry Leaders to Board of Directors, Top Management Roles Learn more
2019-06-24 00:00:00 | A big part of the MS puzzle Learn more
2019-06-21 21:36:29 | Meet Gladstone: Andrew Mendiola
June 21, 2019 Andrew is a postdoctoral scholar in Katerina Akassoglou’s lab. He grew up in Marion, Texas, a small town in-between Austin and San Antonio. Before joining Gladstone, he completed a PhD in cellular and molecular biology with a concentration in immunology at The University of Texas at San Antonio. Click here to read full article.
2019-06-14 20:20:33 | MS News Today – Need to Know: What Is the Blood Brain Barrier?
June 13, 2019 Click here to read full article.
2019-06-12 21:45:41 | Andrew Mendiola Receives an Oral Presentation Award at the Aegean Conference on Innate Immunity – Rhodes, Greece
June 12, 2019
Andrew Mendiola, PhD featured in Momentum, the official magazine of the National MS Society2020-07-21 02:58:32 | Revealing the genetic signature of neurodegenerative disease
To read full article, click here.
2020-07-21 00:00:00 | Revealing the genetic signature of neurodegenerative disease Learn more
2020-04-16 02:54:15 | Scientists Build Map of Toxic Immune Cells Contributing to Neurodegeneration in MS
To read full article, click here.
2020-04-14 02:51:25 | ‘Tox-seq’ atlas of immune cells identified for neurodegenerative therapies
Click here to read full article.
2020-04-14 00:00:00 | Tox-seq’ atlas of immune cells identified for neurodegenerative therapies Learn more
2020-04-13 02:45:26 | Toxic Cell Atlas Guides New Therapies for Neurodegeneration
October 31, 2019 Click here to read the full article.
Gladstone researchers Jae Kyu Ryu, Katerina Akassoglou, and Andrew Mendiola developed a novel method to profile toxic immune cells in the brain, and used it to identify a therapeutic target for multiple sclerosis.
Tox-seq revealed subtypes of brain immune cells that produce toxic reactive oxygen in a mouse model of MS.
2020-02-09 20:00:20 | Mark Petersen – UCSF New Frontier Research ( NFR) Award Recipient
Dr. Petersen has not only been promoted to Associate Professor at the Department of Pediatrics at UCSF; he is also the recipient of the UCSF New Frontier Research pilot award to expand his studies on ACVR1 in neurological diseases.
The New Frontier Research (NFR) is part of the UCSF Sandler Program for Breakthrough Biomedical Research designed to further biomedical discoveries, encourage new areas of exploration , and support emerging talent.2019-12-26 00:00:00 | Ten Greeks Who Left Their Mark in 2019 Learn more
2019-11-15 19:12:14 | Andrew Mendiola shared his research and his Bike MS experience at the National Multiple Sclerosis Leadership Conference
November 15, 2019
2019-11-10 19:43:14 | Mark Petersen is awarded an NIH/NINDS fellowship entitled, “Fibrinogen-Mediated Mechanisms of Preterm Infant Brain Injury.”
November 10, 2019
2019-10-31 22:54:51 | $4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s Disease
October 31, 2019 Click here to read the full article. Jorge Palop (left) and Katerina Akassoglou (right) received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
2019-10-08 23:01:31 | New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease
October 8, 2019 Click here to read full article. Gladstone team of (from left) Jae Kyu Ryu, Anke Meyer-Franke, Katerina Akassoglou, and Stephen Freedman worked with entrepreneur Edward Spack to launch MedaRed, Inc.
2019-10-03 00:00:00 | Deficits in the Blood-Brain Barrier Play a Role in Alzheimer’s Disease Pathology A New 3D Tissue Model Provides a Potential Target for Developing Therapy Learn more
2019-07-11 21:34:44 | Momentum, NMSS Magazine – A big part of the MS puzzle
July 11, 2019 Click here to view article. Momentum_Interview 2019
2019-07-08 00:00:00 | MedaRed Raises $6.5 Million and Appoints Industry Leaders to Board of Directors, Top Management Roles Learn more
2019-06-24 00:00:00 | A big part of the MS puzzle Learn more
2019-06-21 21:36:29 | Meet Gladstone: Andrew Mendiola
June 21, 2019 Andrew is a postdoctoral scholar in Katerina Akassoglou’s lab. He grew up in Marion, Texas, a small town in-between Austin and San Antonio. Before joining Gladstone, he completed a PhD in cellular and molecular biology with a concentration in immunology at The University of Texas at San Antonio. Click here to read full article.
2019-06-14 20:20:33 | MS News Today – Need to Know: What Is the Blood Brain Barrier?
June 13, 2019 Click here to read full article.
2019-06-12 21:45:41 | Andrew Mendiola Receives an Oral Presentation Award at the Aegean Conference on Innate Immunity – Rhodes, Greece
June 12, 2019
